03668nas a2200637 4500000000100000008004100001260001600042653002100058100001400079700001600093700001500109700001200124700001100136700001500147700001300162700001200175700001600187700001400203700001600217700001500233700001900248700001400267700001500281700001300296700001300309700001400322700001700336700001300353700001300366700001400379700002100393700001500414700001100429700001500440700001400455700001400469700001400483700001400497700001300511700001200524700001300536700001200549700001300561700001400574700001300588700001600601700001800617700001400635700001500649245015100664856007500815300001600890490000700906520210300913022001403016 2022 d bElsevier BV10aGeneral Medicine1 aBorlase A1 aLe Rutte EA1 aCastaño S1 aBlok DJ1 aToor J1 aGiardina F1 aDavis EL1 aAliee M1 aAnderson RM1 aAyabina D1 aBasáñez M1 aBlumberg S1 aCaja Rivera RM1 aChitnis N1 aCoffeng LE1 aDavis CN1 aDeiner M1 aDiggle PJ1 aFronterrè C1 aGiorgi E1 aGraham M1 aHamley JI1 aHollingsworth TD1 aKeeling MJ1 aKura K1 aLietman TM1 aMalizia V1 aMedley GF1 aMichael E1 aThumbi SM1 aMutono N1 aPorco T1 aPrada JM1 aRock KS1 aSharma S1 aSpencer S1 aStolk WA1 aTouloupou P1 aVasconcelos A1 aVegvari C1 ade Vlas SJ00aEvaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling study uhttps://www.thelancet.com/action/showPdf?pii=S2214-109X%2822%2900360-6 ae1600-e16110 v103 a

Background: In line with movement restrictions and physical distancing essential for the control of the COVID-19 pandemic, WHO recommended postponement of all neglected tropical disease (NTD) control activities that involve community-based surveys, active case finding, and mass drug administration in April, 2020. Following revised guidance later in 2020, and after interruptions to NTD programmes of varying lengths, NTD programmes gradually restarted in the context of an ongoing pandemic. However, ongoing challenges and service gaps have been reported. This study aimed to evaluate the potential effect of the programmatic interruptions and strategies to mitigate this effect.

Methods: For seven NTDs, namely soil-transmitted helminths, schistosomiasis, lymphatic filariasis, onchocerciasis, trachoma, visceral leishmaniasis, and human African trypanosomiasis, we used mathematical transmission models to simulate the effect of programme interruptions on the dynamics of each of these diseases in different endemic settings. We also explored the potential benefit of implementing mitigation strategies, primarily in terms of minimising the delays to control targets.

Findings: We show that the effect of the COVID-19-induced interruption in terms of delay to achieving elimination goals might in some cases be much longer than the duration of the interruption. For schistosomiasis, onchocerciasis, trachoma, and visceral leishmaniasis, a mean delay of 2–3 years for a 1-year interruption is predicted in areas of highest prevalence. We also show that these delays can largely be mitigated by measures such as additional mass drug administration or enhanced case-finding.

Interpretation: The COVID-19 pandemic has brought infectious disease control to the forefront of global consciousness. It is essential that the NTDs, so long neglected in terms of research and financial support, are not overlooked, and remain a priority in health service planning and funding.

 a2214-109X